DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to “Hold” Rating by StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Tuesday.

XRAY has been the topic of several other reports. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research note on Friday, November 8th. Needham & Company LLC dropped their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Finally, Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded up $0.42 during midday trading on Tuesday, reaching $18.88. 3,937,339 shares of the company were exchanged, compared to its average volume of 3,144,620. The stock has a market cap of $3.75 billion, a PE ratio of -9.12, a price-to-earnings-growth ratio of 1.80 and a beta of 1.02. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $37.60. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The business’s fifty day moving average is $23.66 and its two-hundred day moving average is $25.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same period in the previous year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA’s quarterly revenue was up .4% compared to the same quarter last year. As a group, analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. First Eagle Investment Management LLC increased its stake in shares of DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after purchasing an additional 3,283,965 shares in the last quarter. Nuance Investments LLC raised its position in shares of DENTSPLY SIRONA by 3.8% during the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after purchasing an additional 402,329 shares during the last quarter. FMR LLC lifted its stake in DENTSPLY SIRONA by 5.1% in the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock valued at $245,076,000 after buying an additional 436,031 shares in the last quarter. Cooke & Bieler LP boosted its holdings in DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after buying an additional 1,046,105 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in DENTSPLY SIRONA by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock worth $207,995,000 after buying an additional 343,915 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.